sars-cov-2 recombinant protein antibody detection kit (Autobio Diagnostics)
90
Structured Review
Autobio Diagnostics
sars-cov-2 recombinant protein antibody detection kit
Sars Cov 2 Recombinant Protein Antibody Detection Kit, supplied by Autobio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars-cov-2+recombinant+protein+antibody+detection+kit/anti+sars+cov+2+rapid+test/pm40235093-36-26-32
Average 90 stars, based on 1 article reviews
Sars Cov 2 Recombinant Protein Antibody Detection Kit, supplied by Autobio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars-cov-2+recombinant+protein+antibody+detection+kit/anti+sars+cov+2+rapid+test/pm40235093-36-26-32
Average 90 stars, based on 1 article reviews
sars-cov-2 recombinant protein antibody detection kit - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Vaccines:Article Title: Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination. Article Snippet: In people living with human immunodeficiency virus (HIV, PLWH), the coronavirus disease 2019 (COVID-19) vaccine often results in a limited humoral immune response.. While a reduced absolute CD4þ T cell count is a known factor, other determinants remain unclear.. To investigate variables influencing the differential antibody response to the COVID-19 vaccine in PLWH, 43 HIV-1/AIDS patients receiving antiretroviral therapy (ART) and 2 doses of the COVID-19 vaccine were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immunoglobulin G (IgG) levels and neutralizing antibody (NAb) titers. Recombinant:Article Title: Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination. Article Snippet: In people living with human immunodeficiency virus (HIV, PLWH), the coronavirus disease 2019 (COVID-19) vaccine often results in a limited humoral immune response.. While a reduced absolute CD4þ T cell count is a known factor, other determinants remain unclear.. To investigate variables influencing the differential antibody response to the COVID-19 vaccine in PLWH, 43 HIV-1/AIDS patients receiving antiretroviral therapy (ART) and 2 doses of the COVID-19 vaccine were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immunoglobulin G (IgG) levels and neutralizing antibody (NAb) titers. |